Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Conditions: Hereditary Inclusion Body Myopathy (HIBM); GNE MyopathyIntervention: Drug: ManNAcSponsors: National Human Genome Research Institute (NHGRI); National Center for Advancing Translational Science (NCATS); Therapeutics for Rare and Neglected Diseases (TRND)Completed - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials